Need professional-grade analysis? Visit stockanalysis.com
$41.23B
30.36
17,883
1.66%
Price Chart
Risk-Adjusted Performance
Beijing Tongrentang Co Ltd (600085) Price Performance
Beijing Tongrentang Co Ltd (600085) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY29.70, down 0.83% from the previous close.
Over the past year, 600085 has traded between a low of CNY29.70 and a high of CNY38.14. The stock has lost 19.8% over this period. It is currently 22.1% below its 52-week high.
Beijing Tongrentang Co Ltd has a market capitalization of $41.23B, with a price-to-earnings ratio of 30.36 and a dividend yield of 1.66%.
About Beijing Tongrentang Co Ltd
Beijing Tongrentang Co., Ltd engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally. It operates through the Company, Science Company, Commerce Company, and Others segments. The company offers various product dosage forms, such as pills, powders, alcoholic preparations, capsules, oral liquids, and dripping pills. Its products are used for cardiovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive system, pediatrics, wind and dampness-removing, orthopedics, facial features, dermatology, psychiatric, and food and alcohol. The company also engages in plantation; pharmaceutical retail; aquaculture; investment management; and other related services. The company was founded in 1997 and is based in Beijing, China. Beijing Tongrentang Co., Ltd is a subsidiary of China Beijing Tong Ren Tang Group Co. Ltd.
Company Info
- Sector
- Healthcare
- Exchange
- SHG
- Currency
- CNY
- Country
- China
Financial Metrics
- Revenue (TTM)
- $18.09B
- EBITDA
- $2.62B
- Profit Margin
- 7.49%
- EPS (TTM)
- 0.99
- Book Value
- 9.96
Technical Indicators
- 52 Week High
- CN¥38.36
- 52 Week Low
- CN¥29.60
- 50 Day MA
- CN¥30.77
- 200 Day MA
- CN¥33.81
- Beta
- 0.19
Valuation
- Trailing P/E
- 30.36
- Forward P/E
- 28.17
- Price/Sales
- 2.28
- Price/Book
- 3.03
- Enterprise Value
- $34.49B